Submitted by Anonymous (not verified) on 25 February 2026 - 11:45
Human medicines European public assessment report (EPAR): Gotenfia, golimumab, Date of authorisation: 10/02/2026, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Gotenfia, golimumab, Date of authorisation: 10/02/2026, Status: Authorised